SMITHKLINE BEECHAM WORLDWIDE OTC SALES ADVANCE 11% IN FIRST QUARTER
This article was originally published in The Tan Sheet
Executive Summary
SMITHKLINE BEECHAM WORLDWIDE OTC SALES ADVANCE 11% IN FIRST QUARTER, the company announced April 21. Worldwide sales of OTC products reached (British Pound)150 mil., or $223.5 mil. (based on a translation of 1 (British Pound)= $1.49), with growth in the U.S. aided by the launch of Tums 500 chewable calcium supplement, and the "strong performance" of the Citrucel laxative brand, SmithKline Beecham said.